Evidence map›Paper›PMID 39614933›Full record

ArticleTAG. Theoretical and applied genetics. Theoretische und angewandte Genetik2024

Analytical prediction of genetic contribution across multiple recurrent backcrossing generations.

Temitayo Ajayi, Jason LaCombe, Güven Ince, Trevor Yeats

Abstract read
PubMed Publisher
In one paragraph

Article in TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Temitayo AjayiNature Source Improved Plants, 95 Brown St, Ithaca, NY, 14850, USA. tajayi@nsiplants.com.ORCID http://orcid.org/0000-0003-1819-6462
Jason LaCombeNature Source Improved Plants, 95 Brown St, Ithaca, NY, 14850, USA.
Güven InceNature Source Improved Plants, 95 Brown St, Ithaca, NY, 14850, USA.
Trevor YeatsNature Source Improved Plants, 95 Brown St, Ithaca, NY, 14850, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

key messageWe derive formulas for the residual donor genome content during trait introgression via recurrent backcrossing and use these formulas to predict (without simulation) residual donor genome content for five future generations. Trait introgression is a common method for introducing valuable genes or alleles into breeding populations and inbred cultivars. The particular breeding scheme is usually designed to maximize the genetic similarity of the converted lines to the recurrent parent while minimizing cost and time to recover the near isogenic lines. Key variables include the number of generations and crosses and how to apply genotyping and selection. One form of trait introgression, which is our focus, involves an initial cross of an elite, homozygous recurrent parent line with a non-recurrent, homozygous donor line. The descendants of this cross are backcrossed with the recurrent parent for several generation before self-pollination in the final generation to recover lines with the alleles of interest. In this paper, we derive analytical formulas that characterize the stochastic nature of residual donor genome content during this form of trait introgression. The development of these formulas expands the mathematical methods one can integrate into breeding design. In particular, we show we can use our formulas in a novel mathematical program to allocate resources to optimize the reduction of residual donor genome content.

Indexed as

Crosses, GeneticModels, GeneticPlant BreedingAllelesGenome, PlantGenotypeInbreedingPhenotype

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.